Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
World J Clin Cases ; 7(16): 2346-2351, 2019 Aug 26.
Article in English | MEDLINE | ID: mdl-31531330

ABSTRACT

BACKGROUND: Surgical treatment for large carotid body tumor (CBT), particularly the Shamblin III type, is challenging and rarely reported. CASE SUMMARY: In July 2014, a 63-year-old woman presented to our hospital with a large CBT (130 mm × 60 mm × 70 mm). The lesion was hypervascular, spanned from the first to the seventh cervical vertebra, and adhered to the right common carotid artery (CCA), internal carotid artery (ICA) and external carotid artery (ECA). The resection was carried out in a hybrid operating theatre. First, we used Onyx gel to embolize the feeding artery. An ICA balloon was used to prevent gel entry into the ICA. After shrinkage and hardening of the CBT, we quickly resected the CBT as well as a part of the ECA that adhered to the CBT. A vascular shunt was inserted between CCA and ICA, and the part where the ICA was cut off from the CCA was directly sutured. A follow-up at four years later showed no neurological damage. CONCLUSION: For large hypervascular CBT, embolization of the feeding artery prior to resection is helpful. The hybrid operating theatre is the ideal platform to carry out such operations.

2.
Ai Zheng ; 21(4): 424-9, 2002 Apr.
Article in Chinese | MEDLINE | ID: mdl-12452026

ABSTRACT

BACKGROUND & OBJECTIVE: At present, only few animal experiment has been reported about the pharmacokinetic of peritoneal chemotherapy. The aim of this study was to determine the pharmacokinetic change following large bulk heated hypotonic 5-fluorouracil fluid perfusing into peritoneal immediately after radical resection. METHODS: (1) Fifty patients with gastric cancer after radical resection were randomly assigned into ten groups. They were given intraperitoneal infusion of warm (43 degrees C-45 degrees C) distilled water (1,250 ml/m2) plus 5-fluorouracil (500 mg/L) after radical gastrectomy. At various time intervals (0, 0.08, 0.25, 0.5, 0.75, 1, 3, 6, 12, 24 h), blood samples from the femoral artery and vein, portal vein, and peritoneal fluid were collected. (2) 25 cases of patients with gastric cancer were randomized into five groups, each group also included 5 cases. They were also given intraperitoneal infusion at 1, 3, 6, 12, 24 h with the same fluid before operation, blood samples from portal vein were drawn at the beginning of operation. (3) 5-fluorouracil concentration of above all of samples were determined by high performance liquid chromatography (HPLC). RESULTS: (1) The peak concentration of peritoneal fluid, portal vein, femoral artery and vein were at 0, 0.08, 1.00, 1.00 h, respectively, after peritoneal infusion. (2) The peak and average concentration in peritoneal fluid were 167.7-fold and 180.4-fold as high as that of the femoral vein respectively. (3) The peak and average concentration in portal vein were 5.4-fold and 6.7-fold as high as that of the femoral vein respectively. (4) The concentration changes of 5-fruorouracil in peritoneal fluid, portal vein, femoral artery and vein were all suitable for two compartment open model. The pharmacokinetics parameters of above all the fluid were in turn: AUC0-->tn(mg.L-1.h) 3667.36, 143.82, 31.02, 26.84; alpha(h-1) 1.1076, 0.6269, 7.7923, 21.5643; beta(h-1) 0.0367, 0.0474, 0.2091, 0.2014; CL(L.h-1) 0.16, 4.92, 35.36, 39.32; T1/2 alpha(h) 0.62, 1.11, 0.09, 0.03; T1/2 beta(h) 18.88, 14.64, 3.31, 3.44; (5) The portal vein 5-fluorouracil concentration at various times were all lower than that of the preoperation, suggesting that 5-fluorouracil can pass through retroperitoneal spaces into systemic circulation. CONCLUSION: Postoperative large bulk heated hypotonic fluid peritoneal infusion with 5-fluorouracil has pharmacokinetic characteristic of high selective regional chemotherapy providing higher and lasting concentration in peritoneal fluid and portal vein. Therefore, this method should be a more reasonable chemotherapy for the prevention of recurrence and liver metastasis of gastric cancer after radical resection.


Subject(s)
Antimetabolites, Antineoplastic/pharmacokinetics , Fluorouracil/pharmacokinetics , Liver Neoplasms/metabolism , Postoperative Care , Stomach Neoplasms/metabolism , Humans , Infusions, Parenteral , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Secondary Prevention , Stomach Neoplasms/drug therapy , Stomach Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...